The Breast Implants Market Size was valued at USD 2.58 billion in 2023 and is expected to reach USD 4.63 billion by 2031, and grow at a CAGR of 7.6% over the forecast period 2024-2031.
The field of breast implantation surgery has undergone significant evolution driven by the increasing demand for cosmetic procedures. The revenue of the breast implant market is largely driven by women who prefer to enhance their appearance. As per FDA guidelines, women aged 18 and above are eligible to undergo breast augmentation procedures. According to the American Society of Plastic Surgeons (ASPS), breast augmentation ranks among the top 5 cosmetic procedures performed in the U.S. The ASPS reported that 279,144 procedures for augmenting the breast had been conducted in the U.S. Consequently, given the substantial volume of such cases, it is anticipated that the breast implant market will experience accelerated growth in the upcoming years.
To get more information on Breast Implants Market - Request Sample Report
DRIVERS
Rising Cosmetic Surgery Demand
Rising Incidence of Breast Cancer
In recent years, there has been a significant rise in the global prevalence of breast cancer, driving the demand for improved and more precise treatment approaches. In addition, breast cancer is among the most common types of cancer, and 7.9 million women still alive have been diagnosed in the last five years. This is anticipated to trigger further growth of the market.
RESTRAINTS
High Cost of Procedures
Post Complications and Risks Linked to Breast Implants
Numerous medical journals and public FDA meetings have extensively addressed reports concerning complications experienced by women with implants. These include issues such as capsular contracture, the need for additional surgeries, breast pain, changes in nipple and breast sensation, the formation of scar tissue around the implant leading to compression, rupture, deflation, and breast implant-associated anaplastic hyperplasia, as stated in the official release by the United States Food and Drug Administration (FDA). Consequently, these risks linked with breast implants could impede market expansion.
OPPORTUNITIES
Regenerative Medicine and Stem Cell Technology
Technological Advancement
Due to the latest implant choices and advancements in surgical techniques, breast augmentation has significantly improved. In addition to improving the woman's confidence and body image, it can help her get a natural look. Furthermore, the introduction of Keller Funnel was one of the biggest developments related to breast enhancement. Keller Funnel's like a piping bag used by a pastry chef to frost a cake. When introducing a breast implant, the Keller Funnel may reduce pressure on the implant and body of the patient.
CHALLENGES
Stringent regulations
The challenges for manufacturers are the high requirements of approval and postmarket surveillance. The costs and time involved in the introduction of new products to the market are increased and the growth potential is limited by complying with these regulations.
War contributes to the loss of lives by exacerbating the incidence of cancer. It elevates the likelihood of developing cancer, disrupts and hinders the provision of effective cancer treatment, and exposes vulnerable cancer patients to infections and precarious environments. Additionally, war redirects resources away from cancer care, resulting in delays in diagnosis as individuals prioritize seeking shelter and safety amidst the chaos. Consequently, hospitals and clinics may become overwhelmed, damaged, or destroyed, further impeding timely cancer diagnosis and care and ultimately amplifying mortality rates. A rise in mortality risk of up to 8% has been documented for every four-week postponement in cancer surgeries. Specifically, a 12-week delay in breast cancer surgery is linked with a 26% increase in mortality. Similar associations have been observed across various cancer types such as bladder, colorectal, head and neck, and non-small-cell lung cancer. Furthermore, delays in neoadjuvant and/or adjuvant treatments have been statistically linked to elevated mortality risks in bladder, breast, colorectal, non-small-cell lung, and cervical cancer cases.
Additionally, armed conflicts in various low- and middle-income countries have had detrimental impacts on cancer research. Challenges such as unsafe conditions and environments, insufficient personnel, disruptions in supply chains for equipment, medications, and other necessities, as well as inadequate conditions for meetings, subpar communication systems, and network limitations, have constrained opportunities for research development.
A significant economic slowdown, which has been accompanied by a number of contributing factors, was observed in the breast implant market. One significant aspect is the changing socioeconomic landscape, where consumers may be more cautious with discretionary spending due to economic uncertainties or downturns. This cautious approach often extends to elective procedures such as breast augmentation, resulting in reduced demand for breast implants. In addition, shifts in consumer preferences and priorities may have contributed to the slowing down of growth. In times of financial strain, individuals may prioritize essential expenses over elective medical procedures, leading to a decline in demand for breast implants. Additionally, concerns about job security, income stability, or access to healthcare coverage may deter potential patients from pursuing cosmetic surgeries like breast augmentation. Also, healthcare providers and facilities offering breast implant procedures may be affected by the economic downturn. The profitability of cosmetic surgery practices may be affected by budgetary constraints and reduced patient volumes, leading to reductions in services or the adjustment of pricing strategies for some providers. The overall decrease in the breast implant market is also a consequence of this.
By Product
Silicone Breast Implants
Saline Breast Implants
The highest market share in 2023 was held by silicone breast implants with 83.8%. This is because these devices closely mimic natural breast tissue. For example, the natural shape of the reconstructed breast is created by a gummy implant. There is also no risk for disorders associated with the immune system in this product segment. Due to their soft texture, silicone implants are expected to maintain their dominance over the forecast period. Because of this feature, there is a lower risk for the formation of severe scar tissue surrounding implantation. In addition, the risk of wrinkling is low for gum implants.
By Shape
Round
Anatomical
The biggest revenue in 2023 was made up of round implants, with an 80.8% share. They're ideal for breast enhancement because of their round shape. They tend to look like a compressed sphere. As a result, the demand for these products has been enormous, thus supporting the growth of the market. Round shaped implants are symmetrical, eliminating any problems that may arise during the rotation of the implant. As a result, even surgeons prefer to use round implants instead of anatomical ones. Laboratoires Arion has a broad range of round shaped breast implants. This company, for example, makes Monobloc Silicone, a round shaped implant.
Need any customization research on Breast Implants Market - Enquiry Now
By Application
Reconstructive Surgery
Cosmetic Surgery
In 2023, cosmetic surgery accounted for the largest revenue share and grew at a compound annual growth rate of 7.9%. This is attributed to the increasing prominence of the cosmetic industry, aimed at enhancing aesthetic appeal. Procedures such as breast augmentation within cosmetic surgery contribute to enhancing the appearance of this organ, making breast implantation a pivotal practice in the cosmetic surgery domain. The primary reason why the majority of women seeking breast implants prefer them is because they feel more like natural breast tissue compared to other types of implants.
By End-Use
Hospitals
Cosmetology Clinics
Ambulatory Surgical Centers
As patients increasingly prefer to undergo plastic surgery in hospitals, the hospital segment held the largest market share by 2023. In addition, there is an increase in the number of hospitals being set up in emerging regions due to rising healthcare expenditure.
Regional Analysis
The market for breast implants was dominated by North America, which held a strong position with over 32.9% of the total market and is worth USD 821 million in 2023. A combination of factors, such as the region's advanced health care infrastructure and a growing awareness about beauty treatments, contributes to this supremacy. A pronounced cultural inclination, societal norms, and individual choices in North America seem to fuel a notable demand for breast implants. Also, the robust healthcare facilities in North America, particularly in the United States, facilitate access to cutting-edge surgical interventions, including sophisticated breast augmentation procedures involving implants. The region's economic prosperity is likely to contribute to an increase in the number of people who can afford cosmetic enhancements such as breast enlargement.
Asia Pacific and Latin America are expected to show robust growth with a compound annual growth rate of 7.8% during the forecast period. In developing countries, this is due to an increase in disposable income. In addition, the region has enormous potential in terms of low-cost health tourism treatments. Therefore, the market growth of this region is expected to be driven by these factors. Asia-Pacific emerged as a promising player in the market, experiencing rapid growth driven by increasing disposable incomes and a rising emphasis on physical appearance.
REGIONAL COVERAGE:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of the Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Some of the major key players: ALLERGAN, GC Aesthetics, Mentor Worldwide LLC, Sientra, Inc., Polytech Health & Aesthetics GmbH, Establishment Labs S.A, GROUPE SEBBIN SAS, HANSBIOMED CO. LTD, Shanghai Kangning Medical Supplies Ltd., Laboratoires Arion, and other players.
Aesthetics-Company Financial Analysis
In September 2023, The Mentor is introducing the Motiva Ergonomix, a new type of breast implants aimed at looking and feeling natural. Compared to regular implants, they are made from a special, softer silicone gel.
In June 2023, The Silimed Purethane Implant is made of polyurethane foam. Compared to traditional silicone implants, this material is intended for greater comfort of the body and superior resistance against ruptures.
In February 2023, the acquisition of Life Cell Corporation, a company known for breast implants and surgical products, gave Allergan a boost. This represents an expansion of Allergan's product range and brings to life Life Cell’s expertise in implant technology.
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | US$ 2.58 Billion |
| Market Size by 2031 | US$ 4.63 Billion |
| CAGR | CAGR of 7.6% From 2024 to 2031 |
| Base Year | 2022 |
| Forecast Period | 2024-2031 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product (Silicone Breast Implants, Saline Breast Implants) • By Shape (Round, Anatomical) • By Application (Reconstructive Surgery, Cosmetic Surgery) • By End-use (Hospitals, Cosmetology Clinics, Ambulatory Surgical Centers) |
| Regional Analysis/Coverage | North America (USA, Canada, Mexico), Europe (Germany, UK, France, Italy, Spain, Netherlands, Rest of Europe), Asia-Pacific (Japan, South Korea, China, India, Australia, Rest of Asia-Pacific), The Middle East & Africa (Israel, UAE, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) |
| Company Profiles | ALLERGANGC, Aesthetics, Mentor Worldwide LLC, Sientra, Inc., Polytech Health & Aesthetics GmbH, Establishment Labs S.A, GROUPE SEBBIN SAS, HANSBIOMED CO. LTD, and Shanghai Kangning Medical Supplies Ltd., Laboratoires Arion, and other players. |
| DRIVERS | • Launch of innovative product • Breast augmentation is becoming increasingly popular. |
| RESTRAINTS | • BILA-potential ALCL's to stifle the market |
Ans:- The Breast Implants Market size was valued at US$ 2.58 billion in 2023.
Ans: The Breast Implants Market is to grow at a CAGR of 7.6% over the forecast period 2024-2031
The market is divided into four segments and the segments are By Product, By Product Shape, By Application, and By End User
The challenges faced by the Breast Implants Market is Cosmetic surgery raises social and ethical difficulties.
key drivers of the Breast Implants Market is Launch of innovative product, and Breast augmentation is becoming increasingly popular.
TABLE OF CONTENTS
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Industry Flowchart
3. Research Methodology
4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
5. Impact Analysis
5.1 Impact of Russia-Ukraine Crisis
5.2 Impact of Economic Slowdown on Major Countries
5.2.1 Introduction
5.2.2 United States
5.2.3 Canada
5.2.4 Germany
5.2.5 France
5.2.6 UK
5.2.7 China
5.2.8 Japan
5.2.9 South Korea
5.2.10 India
6. Value Chain Analysis
7. Porter’s 5 Forces Model
8. Pest Analysis
9. Breast Implants Market Segmentation, by Product
9.1 Introduction
9.2 Trend Analysis
9.3 Silicone Breast Implants
9.4 Saline Breast Implants
10. Breast Implants Market Segmentation, by Shape
10.1 Introduction
10.3 Trend Analysis
10.4 Round
10.5 Anatomical
11. Breast Implants Market Segmentation, by Application
11.1 Introduction
11.3 Trend Analysis
11.4 Reconstructive Surgery
11.5 Cosmetic Surgery
12. Breast Implants Market Segmentation, by End-use
12.1 Introduction
12.2 Trend Analysis
12.3 Hospitals
12.4 Cosmetology Clinics
12.5 Ambulatory Surgical Centers
13. Regional Analysis
13.1 Introduction
13.2 North America
13.2.1 USA
13.2.2 Canada
13.2.3 Mexico
13.3 Europe
13.3.1 Eastern Europe
13.3.1.1 Poland
13.3.1.2 Romania
13.3.1.3 Hungary
13.3.1.4 Turkey
13.3.1.5 Rest of Eastern Europe
13.3.2 Western Europe
13.3.2.1 Germany
13.3.2.2 France
13.3.2.3 UK
13.3.2.4 Italy
13.3.2.5 Spain
13.3.2.6 Netherlands
13.3.2.7 Switzerland
13.3.2.8 Austria
13.3.2.9 Rest of Western Europe
13.4 Asia-Pacific
13.4.1 China
13.4.2 India
13.4.3 Japan
13.4.4 South Korea
13.4.5 Vietnam
13.4.6 Singapore
13.4.7 Australia
13.4.8 Rest of Asia Pacific
13.5 The Middle East & Africa
13.5.1 Middle East
13.5.1.1 UAE
13.5.1.2 Egypt
13.5.1.3 Saudi Arabia
13.5.1.4 Qatar
13.5.1.5 Rest of the Middle East
13.5.2 Africa
13.5.2.1 Nigeria
13.5.2.2 South Africa
13.5.2.3 Rest of Africa
13.6 Latin America
13.6.1 Brazil
12.6.2 Argentina
13.6.3 Colombia
13.6.4 Rest of Latin America
14. Company Profiles
14.1 ALLERGANGC
14.1.1 Company Overview
14.1.2 Financial
14.1.3 Products/ Services Offered
14.1.4 SWOT Analysis
14.1.5 The SNS View
14.2 Aesthetics
14.2.1 Company Overview
14.2.2 Financial
14.2.3 Products/ Services Offered
14.2.4 SWOT Analysis
14.2.5 The SNS View
14.3 Mentor Worldwide LLC
14.3.1 Company Overview
14.3.2 Financial
14.3.3 Products/ Services Offered
14.3.4 SWOT Analysis
14.3.5 The SNS View
14.4 Sientra, Inc.
14.4.1 Company Overview
14.4.2 Financial
14.4.3 Products/ Services Offered
14.4.4 SWOT Analysis
14.4.5 The SNS View
14.5 Polytech Health & Aesthetics GmbH
14.5.1 Company Overview
14.5.2 Financial
14.5.3 Products/ Services Offered
14.5.4 SWOT Analysis
14.5.5 The SNS View
14.6 Establishment Labs S.A
14.6.1 Company Overview
14.6.2 Financial
14.6.3 Products/ Services Offered
14.6.4 SWOT Analysis
14.6.5 The SNS View
14.7 GROUPE SEBBIN SAS
14.7.1 Company Overview
14.7.2 Financial
14.7.3 Products/ Services Offered
14.7.4 SWOT Analysis
14.7.5 The SNS View
14.8 HANSBIOMED CO. LTD
14.8.1 Company Overview
14.8.2 Financial
14.8.3 Products/ Services Offered
14.8.4 SWOT Analysis
14.8.5 The SNS View
14.9 Shanghai Kangning Medical Supplies Ltd.
14.9.1 Company Overview
14.9.2 Financial
14.9.3 Products/ Services Offered
14.9.4 SWOT Analysis
14.9.5 The SNS View
14.10 Laboratoires Arion
14.10.1 Company Overview
14.10.2 Financial
14.10.3 Products/ Services Offered
14.10.4 SWOT Analysis
14.10.5 The SNS View
15. Competitive Landscape
15.1 Competitive Benchmarking
15.2 Market Share Analysis
15.3 Recent Developments
15.3.1 Industry News
15.3.2 Company News
15.3.3 Mergers & Acquisitions
16. Use Case and Best Practices
17. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Urinary Incontinence Treatment Devices Market Size was valued at USD 2.44 billion in 2022 and is expected to reach USD 4.46 Billion by 2030 and grow at a CAGR of 7.8% over the forecast period 2023-2030.
The Medical Imaging Market size was valued at USD 28.24 billion in 2022 and is expected to reach at USD 40.47 billion by 2030 and grow at a CAGR of 4.6% over the forecast period of 2023-2030.
The Women’s Health Therapeutics Market size was valued at USD 13.8 billion in 2022 and is expected to reach USD 46.18 billion by 2030 and grow at a CAGR of 16.3% over the forecast period of 2023-2030.
The Autism Spectrum Disorder Treatment Market size was valued at USD 2.13 Billion in 2022 and is expected to reach USD 3.85 Billion By 2030 and grow at a CAGR of 7.7% over the forecast period of 2023-2030.
The Dialysis Market was valued at USD 96.75 Bn in 2022 and is expected to reach USD 151.89 Bn by 2030 and grow at a CAGR of 5.8% over the forecast period of 2023-2030.
In 2022, The Diabetic Neuropathy Market size amounted to USD 5.25 Billion & is estimated to reach USD 10.23 Billion by 2030 and increase at a compound annual growth rate of 8.7% between 2023 and 2030.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
